Dr Marcus Asuquo discusses the pathophysiology of anaemia, and relates it to the safe and effective interventions used to prevent and treat anaemia in bloodless medicine.Dr Marcus Asuquo trained at the University of Calabar and received his basic medical degree, MBBCh, in 1988. He worked as a junior research fellow at the Nigerian Institute of Medical Research (NIMR) for 5 years before going into residency training in Haematology. He had his junior residency training at the University College Hospital (UCH), Ibadan, before proceeding to the Lagos University Teaching Hospital (LUTH) for the senior residency training, and was awarded a Fellowship of the National Postgraduate Medical College in Pathology (FMCPath (Haem)) in 2008.Dr Asuquo was appointed Lecturer I, by the University of Calabar, and Consultant Haematologist by the University of Calabar Teaching Hospital, Calabar all in January 2010. Since then, he has been involved in teaching of medical students, training of residents in haematology and research. He has authored and contributed to many scholarly articles, won research grants and is currently the Principal Investigator for the 54, Gene Heritage study in Cross River State and Unity Global Study for health workers exposed to COVID-19 in Nigeria. His research interest is in blood transfusion avoidance strategies and in haemato- oncology.
Dr Asuquo is the head of the haemato-oncology specialty of the department of haematology and manages many patients with chronic myeloid leukaemia CML in collaboration with the Department of Haematology of Obafemi Awolowo University Teaching Hospital, Ile Ife. He was the National Secretary General of the Nigerian Society for Haematology and Blood Transfusion (NSHBT) from 2014 to 2018, National Secretary of Cancer Education Advocacy Foundation of Nigeria (CEAFON) 2013 to date. He is currently serving as Nigeria’s representative on the Board of the International Society of Haematology (ISH). Dr Asuquo is a member of many professional societies and Associations including Bloodless Medicine & Surgery Society (BMSS), and Society for the Advancement of Blood Management (SABM).
